Novartis Pharmaceuticals Australia Pty Ltd—Lumiracoxib (Prexige)

PRA number


Published date

Product description

100mg tablets (AUST R 128635). 200mg tablets (AUST R 104279). 400mg tablets (AUST R 104280).

Reasons the product is recalled

The Therapeutic Goods Administration has cancelled the registration of Lumiracoxib because of serious liver side effects associated with the use of the drug.

The hazards to consumers

Potentially life-threatening or could cause a serious risk to health (Class I).

What consumers should do

Patients taking Lumiracoxib should stop taking the medicine now and discuss alternative treatments with their doctor.


Novartis Pharmaceuticals Australia Pty Ltd

Where the product was sold


Responsible regulator

Therapeutic Goods Administration is the responsible regulator for this recall.

Product category

Is this page useful?